The FDA has issued an update to its Temporary Policy Regarding Non-Standard PPE Practices for Pharmacy Compounders During the…
FDA Updates Temporary Policy Regarding PPE for Compounders
The FDA has issued an update to its Temporary Policy Regarding Non-Standard PPE Practices for Pharmacy Compounders During the…
May, Mon, 2020
Morphine Sulfate & Epinephrine added to COVID-19 Compounding List
FDA has updated two guidance documents that describe temporary policies for the compounding of certain human drugs during the…
Morphine Sulfate & Epinephrine added to COVID-19 Compounding List
FDA has updated two guidance documents that describe temporary policies for the compounding of certain human drugs during the…
Apr, Fri, 2020
FDA’s Guidance for 503A Compounding of COVID-19
Following our previous posts on FDA’s guidance released this week, Dr. David Hussong discusses the terms stipulated by the…
FDA’s Guidance for 503A Compounding of COVID-19
Following our previous posts on FDA’s guidance released this week, Dr. David Hussong discusses the terms stipulated by the…
Apr, Mon, 2020
503A’s Can Temporarily Compound Certain Drugs
The FDA has issued a temporary guidance which enables 503A compounding pharmacies to compound certain medications without the requirement…
503A’s Can Temporarily Compound Certain Drugs
The FDA has issued a temporary guidance which enables 503A compounding pharmacies to compound certain medications without the requirement…
Apr, Fri, 2020
Updates to FDA’s Policy for Compounding of Hand Sanitizer
On April 15, FDA updated the Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products during the COVID-19 public health emergency.
Updates to FDA’s Policy for Compounding of Hand Sanitizer
On April 15, FDA updated the Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products during the COVID-19 public health emergency.
Apr, Thu, 2020
FDA Relaxes Restrictions on 503Bs for COVID-19
On April 16, 2020, the FDA issued the guidance document “Temporary Policy for Compounding of Certain Drugs for Hospitalized…
FDA Relaxes Restrictions on 503Bs for COVID-19
On April 16, 2020, the FDA issued the guidance document “Temporary Policy for Compounding of Certain Drugs for Hospitalized…
Apr, Fri, 2020
FDA Issues Temporary Policy on PPE for Compounders
FDA has issued a guidance document that addresses the Sterile Compounding Industry’s concerns regarding PPE in light of current…
FDA Issues Temporary Policy on PPE for Compounders
FDA has issued a guidance document that addresses the Sterile Compounding Industry’s concerns regarding PPE in light of current…
Apr, Wed, 2020
FDA Issues Clarification on Compounding Policies
In case you missed it, the FDA sent an email clarifying several compounding policies in response to questions from…
FDA Issues Clarification on Compounding Policies
In case you missed it, the FDA sent an email clarifying several compounding policies in response to questions from…
Apr, Tue, 2020
More on FDA’s EUA for Hydroxychloroquine
More on FDA’s EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate Here’s what Eagle’s Chief Technical Officer and the current…
More on FDA’s EUA for Hydroxychloroquine
More on FDA’s EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate Here’s what Eagle’s Chief Technical Officer and the current…
Mar, Mon, 2020
FDA Issues EUA for the Use of Hydroxychloroquine and Chloroquine
On Sunday March 29, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to permit…
FDA Issues EUA for the Use of Hydroxychloroquine and Chloroquine
On Sunday March 29, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to permit…